You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Autoantibodies, Oral Submucous Fibrosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triamcinolone, Pentoxifylline, Vitamin E Trial in Karachi (Triamcinolone, Pentoxifylline with Vitamin E)

Completed
  • Triamcinolone
  • +4 more
  • Karachi, Sindh, Pakistan
    Altamash Institute of Dental Medicine
Dec 13, 2022

Oral Submucous Fibrosis Trial in Karachi (Nigella sativa oil, Betamethasone Valerate)

Completed
  • Oral Submucous Fibrosis
  • Nigella sativa oil
  • Betamethasone Valerate
  • Karachi, Sindh, Pakistan
    Ziauddin University, Clifton
Mar 14, 2022

Oral Cancer Screening and Education in Hong Kong

Not yet recruiting
  • Oral Cancer
  • +5 more
  • No intervention utilised
  • (no location specified)
Jul 22, 2020

Oral Epithelial Dysplasia Informational Needs Questionnaire

Completed
  • Oral Epithelial Dysplasia
  • +23 more
  • No intervention is planned for this study
  • London, United Kingdom
    University college london hospitals
Mar 31, 2020

Functional Dimensions of Macintosh Laryngoscope Blade During

Recruiting
  • Submucous Fibrosis
  • Direct Laryngoscopy
  • New Delhi, India
    Sir Ganga Ram Hospital
Oct 1, 2022

Laser Hysteroscopic Ablation of Submucous Myoma Trial in Barcelona (hysteroscopic ablation of submucous uterine fibroid using

Completed
  • Laser Hysteroscopic Ablation of Submucous Myoma
  • hysteroscopic ablation of submucous uterine fibroid using diode laser
  • Barcelona, Spain
    Parc de Salut Mar
Nov 3, 2022

Scleroderma, Systemic Sclerosis Trial in France (clopidogrel treatment, Placebo)

Recruiting
  • Scleroderma
  • Systemic Sclerosis
  • clopidogrel treatment
  • Placebo
  • Bordeaux, France
  • +8 more
Oct 17, 2022

Cystic Fibrosis, Periodontitis, Gingivitis Trial in Reims (Periodontal examination)

Recruiting
  • Cystic Fibrosis
  • +2 more
  • Periodontal examination
  • Reims, France
    Damien JOLLY
Nov 10, 2023

Idiopathic Pulmonary Fibrosis Trial in Worldwide (MBS2320, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Fresno, California
  • +59 more
Jul 10, 2023

Inferior Turbinate Hypertrophy Trial in Mansoura (Medial Flap Coblation Turbinoplasty, Submucous Resection)

Completed
  • Inferior Turbinate Hypertrophy
  • Medial Flap Coblation Turbinoplasty
  • Submucous Resection
  • Mansoura, Egypt
    Mansoura University faculty of Medicine
Feb 21, 2023

Hysteroscopic Myomectomy for Submucosal Myomas Without Energy

Recruiting
  • Hysteroscopic Myomectomy
    • Yiwu, Zhejiang, China
      Xu Wanwan
    Nov 28, 2023

    Evolution of Pre Type 1 Diabetes With Adult ONset

    Active, not recruiting
    • Type 1 Diabetes
    • Type 1 Diabetes Mellitus Maturity Onset
    • High genetic risk for type 1 diabetes
    • High gentic risk for Coeliac disease
    • Exeter, Devon, United Kingdom
      NIHR Exeter Clinical Research Facility (Royal Devon University H
    Aug 16, 2023

    Idiopathic Pulmonary Fibrosis Trial (Ifetroban Sodium, Placebo)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • Ifetroban Sodium
    • Placebo
    • (no location specified)
    Jan 25, 2023

    Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation Trial (Sodium Fusidate, Placebo)

    Not yet recruiting
    • Cystic Fibrosis
    • Cystic Fibrosis Pulmonary Exacerbation
    • Sodium Fusidate
    • Placebo
    • (no location specified)
    Dec 14, 2022

    Metabolic Syndrome, Cardiac Fibrosis Trial in L'Aquila (Inositol and alpha-lactalbumin)

    Recruiting
    • Metabolic Syndrome
    • Cardiac Fibrosis
    • Inositol and alpha-lactalbumin
    • L'Aquila, Italy
      UOC Medicina Interna e Nefrologia P.O. AQ
    Jan 18, 2023

    Idiopathic Pulmonary Fibrosis, Acute Fatal Form Trial in United States (Autoantibody Reductive Therapy, Treatment as Usual

    Recruiting
    • Idiopathic Pulmonary Fibrosis, Acute Fatal Form
    • Autoantibody Reductive Therapy
    • Treatment as Usual (TAU)
    • Birmingham, Alabama
    • +6 more
    Sep 5, 2022

    Idiopathic Pulmonary Fibrosis Trial (TTI-101, Placebo)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • (no location specified)
    Jan 3, 2023

    Autoimmunity and Obesity in Polycystic Ovary Syndrome

    Not yet recruiting
    • Polycystic Ovary Syndrome
      • Sohag, Egypt
        Sohag university
      Jul 1, 2023

      Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex Trial in United States (Cannabidiol)

      Recruiting
      • Lennox Gastaut Syndrome
      • +2 more
      • Downey, California
      • +30 more
      Aug 4, 2022

      Periodontitis, Rheumatoid Arthritis Trial in Kuala Lumpur (Nonsurgical periodontal therapy)

      Recruiting
      • Periodontitis
      • Rheumatoid Arthritis
      • Nonsurgical periodontal therapy
      • Kuala Lumpur, Federal Territory, Malaysia
        Universiti Malaya
      May 18, 2023

      Metabolic Associated Fatty Liver Disease Trial (dapagliflozin (Forxiga))

      Not yet recruiting
      • Metabolic Associated Fatty Liver Disease
      • dapagliflozin (Forxiga)
      • (no location specified)
      Mar 13, 2023

      Generalized Myasthenia Gravis Trial in Spain, United States (ALXN1720, Placebo)

      Recruiting
      • Generalized Myasthenia Gravis
      • ALXN1720
      • Placebo
      • Gainesville, Georgia
      • +7 more
      Dec 20, 2022

      Ambulatory IPF Trial in United States (Rituximab, Placebo)

      Completed
      Has Results
      • Ambulatory IPF
      • Birmingham, Alabama
      • +6 more
      Jan 20, 2022

      Commercial Assay for the Detection of Neuronal Antibodies

      Completed
      • Paraneoplastic Neurological Syndrome
      • Autoimmune Encephalitis
      • Indirect immunofluorescence assay on tissue slides and cell-based assays with CSF and/or sera
      • Bron, France
      • +1 more
      Mar 13, 2023

      Immune-response in Autoimmune Encephalitis and Paraneoplastic

      Recruiting
      • Autoimmune Encephalitis
      • Paraneoplastic Neurological Syndrome
      • Genetic and immunology tests
      • Lyon, France
        Centre de référence des syndromes neurologiques paranéoplasiques
      Mar 6, 2023